newsfilter
← Latest News
GlobeNewswire·

Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta's Community to Accelerate Recruitment to Povetacicept Clinical Trials

BELLEVUE and SEATTLE, Wash., March 22, 2023 (GLOBE NEWSWIRE) -- Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced a strategic partnership to help accelerate clinical trial recruitment for